Long-term maternal and child outcomes following postnatal SSRI treatment

Duration: 12 mins Publication Date: 20 Nov 2024 Next Review Date: 20 Feb 2027 DOI: 10.13056/acamh.13786

Description

In this talk, Dr. Kate Liu examines the lasting effects of untreated postnatal depression. While SSRIs are commonly recommended for moderate to severe postnatal depression, concerns about their long-term safety in children create hesitations in treatment. To address this, she presents a study tracking over 60,000 mother-child pairs in Norway, investigating the impact of postnatal SSRI use on children’s emotional, behavioral, motor, and language development over the first five years of life. Her study design overcomes key limitations of previous research, providing a more comprehensive and reliable understanding of long-term child outcomes following postnatal SSRI use.

Learning Objectives

A. To understand postnatal depression and its treatment options

B. To understand the barriers preventing women from getting treatment

C. To recognize the benefits and risk of postnatal SSRI treatment


About this Lesson

Speakers

The Association for Child and Adolescent Mental Health
We're a Living Wage Employer
© ACAMH
St Saviour’s House, 39-41 Union Street, London SE1 1SD
+44 (0)20 7403 7458
acamh footer acamh footer
DISCLAIMER: While all transcripts were created by professional transcribers (unless otherwise stated), some may contain mistranslations resulting in inaccurate or nonsensical word combinations, or unintentional language. ACAMH is not responsible and will not be held liable for damages, financial or otherwise, that occur as a result of transcript inaccuracies.
}